Reactome | NEU1,4 hydrolyze PSAP(195-273):GM3:PE

NEU1,4 hydrolyze PSAP(195-273):GM3:PE

Stable Identifier

R-HSA-1605724

Type

Reaction [transition]

Species

Homo sapiens

Compartment

lysosomal lumen

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Ganglioside GM3, mobilized by Saposin B (PSAP(195-273)), is hydrolyzed by sialidases to lactosylceramide (LacCer). Sialidases (NEU, neuraminidases) hydrolyze sialic acids (N-acetylneuramic acid, Neu5Ac, NANA) to produce asialo compounds, a step in the degradation process of glycoproteins and gangliosides. NEU1 and NEU4 hydrolyse NANA in the lysosomal lumen. NEU1 is active in a multienzyme complex comprising cathepsin A protective protein (CTSA) and beta-galactosidase (Bonten et al. 1996, Rudenko et al. 1995). Defects in NEU1 cause Sialidosis (MIM:256550) (Bonten et al. 1996). CTSA appears to exert a protective function necessary for the stability and activity of these enzymes (Galjart et al. 1988). Defects in CTSA are the cause of galactosialidosis (GSL, MIM:256540) (Zhou et al. 1991). NEU4 is also a lysosomal sialidase which, unlike NEU1, does not require association with other proteins for enzymatic activity. Isoform 2 seems to be the lysosomal sialidase (Seyrantepe et al. 2004). Researchers observed elevated GM3 in prosaposin deficiency (PSAPD, MIM: 611721) cases, a rare disease with low levels of all saposins. The essential cofactor missing appears to be Saposin B (PSAP(195-273)) (Schmidt et al., 1992; Bradova et al., 1993).

Literature References

PubMed ID	Title	Journal	Year
1634229	Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders Schmid, B, Paton, BC, Harzer, K, Sandhoff, K	Hum Genet	1992
8370580	Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease Paton, BC, Harzer, K, Smíd, F, Bradová, V, Ulrich-Bott, B, Roggendorf, W	Hum Genet	1993
15213228	Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells Landry, K, Hassan, JA, Trudel, S, Pshezhetsky, AV, Seyrantepe, V, Morales, CR	J Biol Chem	2004
8591035	Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism Hol, WG, Rudenko, G, d'Azzo, A, Bonten, E	Structure	1995
1756715	A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable Zhou, XY, Gillemans, N, Willemsen, R, d'Azzo, A, Galjart, NJ, Galjaard, H	EMBO J	1991
8985184	Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis van der Spoel, A, Grosveld, G, d'Azzo, A, Fornerod, M, Bonten, E	Genes Dev	1996
3136930	Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases Verheijen, FW, Harris, A, van der Horst, GT, Gillemans, N, d'Azzo, A, Galjart, NJ, Galjaard, H	Cell	1988